tiprankstipranks
Trending News
More News >
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
US Market

IDEAYA Biosciences (IDYA) Blogger Opinions & Sentiment

Compare
635 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
IDYA Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
75% SeekingAlpha
25% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away
SeekingAlpha
IDEAYA Biosciences: Positive Darovasertib Data In Neo-Adjuvant Melanoma Sets Next Catalyst
SeekingAlpha
Ideaya Biosciences: Moving Into ADCs For Solid Tumors
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of IDYA?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of IDYA?
    Currently there's no blogger sentiment for IDYA.
    What Is IDYA’s Blogger Sentiment?
    IDYA’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for IDYA?
      The most recent blogger prediction for IDYA was made by Edmund Ingham, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          MRKMerck & Company
          BMYBristol-Myers Squibb
          NVONovo Nordisk
          CRSPCrispr Therapeutics AG
          VKTXViking Therapeutics